Nifuroxazide modulates hepatic expression of LXRs/SR-BI/CES1/CYP7A1 and LDL-R and attenuates experimentally-induced hypercholesterolemia and the associated cardiovascular complications.

Autor: Hasson TS; Dep. of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt., Said E; Dep. of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt; Faculty of Pharmacy, New Mansoura University, New Mansoura, Egypt. Electronic address: emansaid@mans.edu.eg., Helal MG; Dep. of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.

Publikováno v: Life sciences [Life Sci] 2022 Oct 01; Vol. 306, pp. 120790. Date of Electronic Publication: 2022 Jul 09.